Depression in patients with Parkinson's disease: current understanding of its neurobiology and implications for treatment
S Prange, H Klinger, C Laurencin, T Danaila… - Drugs & Aging, 2022 - Springer
Depression is one of the most frequent and burdensome non-motor symptoms in
Parkinson's disease (PD), across all stages. Even when its severity is mild, PD depression …
Parkinson's disease (PD), across all stages. Even when its severity is mild, PD depression …
Apathy in Parkinson's disease: clinical features, neural substrates, diagnosis, and treatment
J Pagonabarraga, J Kulisevsky, AP Strafella… - The Lancet …, 2015 - thelancet.com
Normal maintenance of human motivation depends on the integrity of subcortical structures
that link the prefrontal cortex with the limbic system. Structural and functional disruption of …
that link the prefrontal cortex with the limbic system. Structural and functional disruption of …
The Parkinson's progression markers initiative (PPMI)–establishing a PD biomarker cohort
K Marek, S Chowdhury, A Siderowf… - Annals of clinical …, 2018 - Wiley Online Library
Abstract Objective The Parkinson's Progression Markers Initiative (PPMI) is an
observational, international study designed to establish biomarker‐defined cohorts and …
observational, international study designed to establish biomarker‐defined cohorts and …
Biomarkers for Parkinson's disease: recent advancement
S Lotankar, KS Prabhavalkar, LK Bhatt - Neuroscience bulletin, 2017 - Springer
As a multi-factorial degenerative disease, Parkinson's disease (PD) leads to tremor, gait
rigidity, and hypokinesia, thus hampering normal living. As this disease is usually detected …
rigidity, and hypokinesia, thus hampering normal living. As this disease is usually detected …
Executive dysfunction in P arkinson's disease: A review
G Dirnberger, M Jahanshahi - Journal of neuropsychology, 2013 - Wiley Online Library
Executive dysfunction can be present from the early stages of P arkinson's disease (PD). It is
characterized by deficits in internal control of attention, set shifting, planning, inhibitory …
characterized by deficits in internal control of attention, set shifting, planning, inhibitory …
The spectrum of nonmotor symptoms in early Parkinson disease
Objective: Nonmotor symptoms (NMS) are common in patients with established Parkinson
disease (PD) but their frequency in early PD has not been extensively studied. Our aim was …
disease (PD) but their frequency in early PD has not been extensively studied. Our aim was …
Sleep and circadian rhythm regulation in early Parkinson disease
Importance Sleep disturbances are recognized as a common nonmotor complaint in
Parkinson disease but their etiology is poorly understood. Objective To define the sleep and …
Parkinson disease but their etiology is poorly understood. Objective To define the sleep and …
Depression in Parkinson disease—epidemiology, mechanisms and management
D Aarsland, S Påhlhagen, CG Ballard, U Ehrt… - Nature Reviews …, 2012 - nature.com
Depression occurs in around 35% of patients with Parkinson disease (PD) and is often
persistent. Symptoms of depression can be evident in individuals at the time of diagnosis …
persistent. Symptoms of depression can be evident in individuals at the time of diagnosis …
Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms
MC Rodriguez-Oroz, M Jahanshahi, P Krack… - The Lancet …, 2009 - thelancet.com
A dopaminergic deficiency in patients with Parkinson's disease (PD) causes abnormalities of
movement, behaviour, learning, and emotions. The main motor features (ie, tremor, rigidity …
movement, behaviour, learning, and emotions. The main motor features (ie, tremor, rigidity …
Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease
D Weintraub, T Simuni, C Caspell‐Garcia… - Movement …, 2015 - Wiley Online Library
This study was undertaken to determine the prevalence and correlates of cognitive
impairment (CI) and neuropsychiatric symptoms (NPS) in early, untreated patients with …
impairment (CI) and neuropsychiatric symptoms (NPS) in early, untreated patients with …